Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2012

Open Access 01-12-2012 | Research article

Improving HIV outcomes in resource-limited countries: the importance of quality indicators

Authors: Aima A Ahonkhai, Ingrid V Bassett, Timothy G Ferris, Kenneth A Freedberg

Published in: BMC Health Services Research | Issue 1/2012

Login to get access

Abstract

Background

Resource-limited countries increasingly depend on quality indicators to improve outcomes within HIV treatment programs, but indicators of program performance suitable for use at the local program level remain underdeveloped.

Methods

Using the existing literature as a guide, we applied standard quality improvement (QI) concepts to the continuum of HIV care from HIV diagnosis, to enrollment and retention in care, and highlighted critical service delivery process steps to identify opportunities for performance indicator development. We then identified existing indicators to measure program performance, citing examples used by pivotal donor agencies, and assessed their feasibility for use in surveying local program performance. Clinical delivery steps without existing performance measures were identified as opportunities for measure development. Using National Quality Forum (NQF) criteria as a guide, we developed measurement concepts suitable for use at the local program level that address existing gaps in program performance assessment.

Results

This analysis of the HIV continuum of care identified seven critical process steps providing numerous opportunities for performance measurement. Analysis of care delivery process steps and the application of NQF criteria identified 24 new measure concepts that are potentially useful for improving operational performance in HIV care at the local level.

Conclusion

An evidence-based set of program-level quality indicators is critical for the improvement of HIV care in resource-limited settings. These performance indicators should be utilized as treatment programs continue to grow.
Appendix
Available only for authorised users
Literature
1.
2.
3.
4.
5.
UNAIDS: Global HIV/AIDS response: epidemic update and health sector progress towards universal access, progress report 2011. 2011, cited 2012 15 April
6.
Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, et al: Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009, 52: 397-405. 10.1097/QAI.0b013e3181ab73e2.PubMedPubMedCentral
7.
Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al: Who starts antiretroviral therapy in Durban, South Africa?… not everyone who should. AIDS. 2010, 24 (Suppl 1): S37-S44. 10.1097/01.aids.0000366081.91192.1c.PubMedPubMedCentral
8.
Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, et al: Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009, 51: 135-139. 10.1097/QAI.0b013e3181a44ef2.PubMedPubMedCentral
9.
Fox MP, Rosen S: Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health. 2010, 15 (Suppl 1): 1-15.PubMedPubMedCentral
10.
Brinkhof MW, Pujades-Rodriguez M, Egger M: Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009, 4: e5790-10.1371/journal.pone.0005790.PubMedPubMedCentral
11.
Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006, 367 (9513): 817-824.PubMed
12.
Lawn SD, Harries AD, Anglaret X, Myer L, Wood R: Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008, 22: 1897-1908. 10.1097/QAD.0b013e32830007cd.PubMed
13.
14.
Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, Spohr M, et al: Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ. 2008, 86: 939-947. 10.2471/BLT.07.049908.PubMedPubMedCentral
15.
16.
Langley GJ, Nolan K, Nolan TW: The foundation of improvement. 1992, MD: API Publishing, Silver Spring
17.
Leatherman S, Ferris TG, Berwick D, Omaswa F, Crisp N: The role of quality improvement in strengthening health systems in developing countries. Int J Qual Health C. 2010, 22 (4): 237-243. 10.1093/intqhc/mzq028.
18.
Donabedian A: Explorations in Quality Assessment and Monitoring. 1980, Ann Arbor: Health Administration Press
19.
Campbell SM, Roland MO, Buetow SA: Defining quality of care. Soc Sci Med. 2000, 51: 1611-1625. 10.1016/S0277-9536(00)00057-5.PubMed
20.
Kaplan RS, Norton DP: The balanced scorecard–measures that drive performance. Harv Bus Rev. 1992, 70: 71-79.PubMed
21.
Langley GL, Nolan KM, Nolan TM, Norman CL, Provost LP: The Improvement Guide: A Practical Approach to Enhancing Organizational Performance. 2009, San Francisco: Jossey-Bass Publishers
22.
23.
24.
25.
26.
27.
28.
The Global Fund to Fight AIDS, Tuberculosis, and Malaria: Monitoring and evaluation toolkit: HIV, tuberculosis and malaria and health systems strengthening. 2009
29.
30.
31.
32.
33.
Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al: Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002, 360: 119-129. 10.1016/S0140-6736(02)09411-4.PubMed
34.
Eisenberg JM, Power EJ: Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality. JAMA. 2000, 284: 2100-2107. 10.1001/jama.284.16.2100.PubMed
35.
McNairy ML, El-Sadr WM: The HIV care continuum: no partial credit given. AIDS. 2012, Epub ahead of print
36.
Bateganya MH, Abdulwadud OA, Kiene SM: Home-based HIV voluntary counseling and testing in developing countries. Cochrane Database Syst Rev. 2007, CD006493.
37.
Wanyenze RK, Nawavvu C, Namale AS, Mayanja B, Bunnell R, Abang B, et al: Acceptability of routine HIV counseling and testing, and HIV seroprevalence in Ugandan hospitals. Bull World Health Organ. 2008, 86: 302-309. 10.2471/BLT.07.042580.PubMedPubMedCentral
38.
Helleringer S, Kohler HP, Frimpong JA, Mkandawire J: Increasing uptake of HIV testing and counseling among the poorest in sub-Saharan countries through home-based service provision. J Acquir Immune Defic Syndr. 2009, 51: 185-193. 10.1097/QAI.0b013e31819c1726.PubMedPubMedCentral
39.
40.
Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, et al: The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011, 8: e1001102-10.1371/journal.pmed.1001102.PubMedPubMedCentral
41.
Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G, et al: Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010, 55: 245-252. 10.1097/QAI.0b013e3181e9e069.PubMed
42.
Bateganya M, Abdulwadud OA, Kiene SM: Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing. Cochrane Database Syst Rev. 2010, 7: CD006493.PubMed
43.
Kayigamba FR, Bakker MI, Fikse H, Mugisha V, Asiimwe A, Schim van der Loeff MF: Patient enrolment into HIV care and treatment within 90 days of HIV diagnosis in eight Rwandan health facilities: a review of facility-based registers. PLoS One. 2012, 7: e36792-10.1371/journal.pone.0036792.PubMedPubMedCentral
44.
Rosen S, Fox MP: Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011, 8: e1001056-10.1371/journal.pmed.1001056.PubMedPubMedCentral
45.
Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007, 4: e298-10.1371/journal.pmed.0040298.PubMedPubMedCentral
46.
Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, et al: The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010, 5: e9538-10.1371/journal.pone.0009538.PubMedPubMedCentral
47.
48.
Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, et al: Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009, 373: 1352-1363.PubMed
49.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011, 365: 493-505. 10.1056/NEJMoa1105243.PubMedPubMedCentral
50.
51.
52.
Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al: Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011, 8: e1000391-10.1371/journal.pmed.1000391.PubMedPubMedCentral
53.
Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al: Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010, 375 (9729): 1920-1937. 10.1016/S0140-6736(10)60359-5.PubMed
54.
Small PM, Pai M: Tuberculosis diagnosis–time for a game change. N Engl J Med. 2010, 363: 1070-1071. 10.1056/NEJMe1008496.PubMed
55.
Weiser SD, Fernandes KA, Brandson EK, Lima VD, Anema A, Bangsberg DR, et al: The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr. 2009, 52: 342-349. 10.1097/QAI.0b013e3181b627c2.PubMedPubMedCentral
56.
Anema A, Vogenthaler N, Frongillo EA, Kadiyala S, Weiser SD: Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities. Curr HIV/AIDS Rep. 2009, 6: 224-231. 10.1007/s11904-009-0030-z.PubMed
57.
Ivers LC, Cullen KA, Freedberg KA, Block S, Coates J, Webb P: HIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis. 2009, 49: 1096-1102. 10.1086/605573.PubMedPubMedCentral
58.
Ivers LC, Chang Y, Gregory Jerome J, Freedberg KA: Food assistance is associated with improved body mass index, food security and attendance at clinic in an HIV program in central Haiti: a prospective observational cohort study. AIDS Res Ther. 2010, 7: 33-10.1186/1742-6405-7-33.PubMedPubMedCentral
59.
Ndekha M, van Oosterhout JJ, Saloojee H, Pettifor J, Manary M: Nutritional status of Malawian adults on antiretroviral therapy 1 year after supplementary feeding in the first 3 months of therapy. Trop Med Int Health. 2009, 14: 1059-1063. 10.1111/j.1365-3156.2009.02322.x.PubMed
60.
Weiser SD, Gupta R, Tsai AC, Frongille EA, Grede N, Kumbakumba E, et al: Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda. J Acquir Immune Defic Syndr. 2012, Epub ahead of print
61.
Bassett IV, Giddy J, Nkera J, Wang B, Losina E, Lu Z, et al: Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr. 2007, 46: 181-186. 10.1097/QAI.0b013e31814277c8.PubMedPubMedCentral
62.
National Department of Health South Africa: National antiretroviral treatment guidelines. 2004
63.
Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, et al: Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009, 9: 290-10.1186/1471-2458-9-290.PubMedPubMedCentral
64.
Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, Deuffic-Burban S, et al: Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire. PLoS One. 2010, 5: e13414-10.1371/journal.pone.0013414.PubMedPubMedCentral
65.
Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS: Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 3): S112-S117.PubMed
66.
Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, et al: Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012, 7: e39894-10.1371/journal.pone.0039894.PubMedPubMedCentral
67.
Lawn SD, Myer L, Orrell C, Bekker LG, Wood R: Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005, 19: 2141-2148. 10.1097/01.aids.0000194802.89540.e1.PubMed
68.
Kranzer K, Ford N: Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Trop Med Int Heallth. 2011, 16: 1297-1313. 10.1111/j.1365-3156.2011.02828.x.
69.
Ahonkhai AA, Noubary F, Munro A, Stark R, Wilke M, Freedberg KA, et al: Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program. PLoS One. 2012, 7: e32993-10.1371/journal.pone.0032993.PubMedPubMedCentral
70.
Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R: Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis. 2006, 43: 770-776. 10.1086/507095.PubMed
71.
Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM: Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2010, 10: 155-166. 10.1016/S1473-3099(09)70328-7.PubMed
72.
Ivers LC, Kendrick D, Doucette K: Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005, 41: 217-224. 10.1086/431199.PubMed
73.
Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R, et al: Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS. 2008, 22: 2291-2302. 10.1097/QAD.0b013e3283121ca9.PubMedPubMedCentral
74.
Keiser O, MacPhail P, Boulle A, Wood R, Schechter M, Dabis F, et al: Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy. Trop Med Int Health. 2009, 14: 1220-1225. 10.1111/j.1365-3156.2009.02338.x.PubMedPubMedCentral
75.
Tuboi SH, Brinkhof MW, Egger M, Stone RA, Braitstein P, Nash D, et al: Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration. J Acquir Immune Defic Syndr. 2007, 45: 52-59. 10.1097/QAI.0b013e318042e1c3.PubMed
76.
Harries AD, Zachariah R, van Oosterhout JJ, Reid SD, Hosseinipour MC, Arendt V, et al: Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis. 2010, 10: 60-65. 10.1016/S1473-3099(09)70321-4.PubMed
77.
78.
Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al: Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010, 53: 405-411. 10.1097/QAI.0b013e3181b843f0.PubMedPubMedCentral
79.
Institute of Medicine: Crossing the quality chasm: a new health system for the 21st century. 2001, Washington, DC: National Academy Press
80.
Wu AW: Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS. 2000, 14: 1449-1451. 10.1097/00002030-200007070-00019.PubMed
81.
Clayson DJ, Wild DJ, Quarterman P, Duprat-Lomon I, Kubin M, Coons SJ: A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. Pharmacoeconomics. 2006, 24: 751-765. 10.2165/00019053-200624080-00003.PubMed
82.
da Silva J, Bunn K, Bertoni RF, Neves OA, Traebert J: Quality of life of people living with HIV. AIDS Care. 2012, Epub ahead of print
83.
The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995, 41: 1403-1409.
84.
Duracinsky M, Herrmann S, Berzins B, Armstrong AR, Kohli R, Le Coeur S, et al: The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS. J Acquir Immune Defic Syndr. 2012, 59: 498-505. 10.1097/QAI.0b013e318245cafe.PubMed
85.
Wu AW, Revicki DA, Jacobson D, Malitz FE: Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997, 6: 481-493. 10.1023/A:1018451930750.PubMed
86.
Cella DF, McCain NL, Peterman AH, Mo F, Wolen D: Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qua Life Res. 1996, 5: 450-463. 10.1007/BF00449920.
87.
Ganz WI, Sridhar KS, Forness TJ: Detection of early anthracycline cardiotoxicity by monitoring the peak filling rate. Am J Clin Onc. 1993, 16: 109-112. 10.1097/00000421-199304000-00005.
88.
Holmes WC, Shea JA: A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: development, reliability, and validity. Med Care. 1998, 36: 138-154. 10.1097/00005650-199802000-00004.PubMed
89.
Lubeck DP, Fries JF: Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res. 1997, 6: 494-506. 10.1023/A:1018404014821.PubMed
90.
Smith KW, Avis NE, Mayer KH, Swislow L: Use of the MQoL-HIV with asymptomatic HIV-positive patients. Qual Life Res. 1997, 6: 555-560. 10.1023/A:1018412216638.PubMed
91.
Narayan D, Patel R, Schafft K, Rademacher A, Koch-Schulte S: Voices of the Poor: Can Anyone Hear Us?. 2000, New York: Oxford University Press
92.
Unge C, Sodergard B, Marrone G, Thorson A, Lukhwaro A, Carter J, et al: Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. PLoS One. 2010, 5: e13613-10.1371/journal.pone.0013613.PubMedPubMedCentral
93.
Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al: Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007, 19: 658-665. 10.1080/09540120701244943.PubMed
94.
Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD: Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010, 14: 778-784. 10.1007/s10461-009-9533-2.PubMed
95.
Pascoe GC: Patient satisfaction in primary health care: a literature review and analysis. Eval Program Plann. 1983, 6: 185-210. 10.1016/0149-7189(83)90002-2.PubMed
96.
Njilele AC, Ukwe CV, Okonta JM, Ekwunife OI: Development of a patient satisfaction questionnaire for HIV/AIDS patients in Nigeria. Int J Clin Pharm. 2012, 34 (1): 98-104. 10.1007/s11096-011-9596-9.PubMed
97.
Kagashe GA, Rwebangila F: Patient satisfaction with health care services provided at HIV clinics at Amana and Muhimbili hospitals in Dar es Salaam. Afr Health Sci. 2011, 11 (Suppl 1): S60-S66.PubMedPubMedCentral
98.
Nwabueze SA, Adogu PO, Ilika AL, Asuzu MC, Adinma ED: Perception of quality of care in HIV/AIDS programmes among patients in a tertiary health care facility in Anambra State. Niger J Med. 2011, 20: 144-150.PubMed
99.
Devnani M, Gupta AK, Wanchu A, Sharma RK: Factors associated with health service satisfaction among people living with HIV/AIDS: a cross sectional study at ART center in Chandigarh. India AIDS Care. 2012, 24: 100-107. 10.1080/09540121.2011.592816.PubMed
100.
Wouters E, Heunis C, van Rensburg D, Meulemans H: Patient satisfaction with antiretroviral services at primary health-care facilities in the Free State, South Africa–a two-year study using four waves of cross-sectional data. BMC Health Serv Res. 2008, 8: 210-10.1186/1472-6963-8-210.PubMedPubMedCentral
101.
Myburgh NG, Solanki GC, Smith MJ, Lalloo R: Patient satisfaction with health care providers in South Africa: the influences of race and socioeconomic status. Int J Qual Health C. 2005, 17: 473-477. 10.1093/intqhc/mzi062.
102.
ACTG: ACTG Self Report Questionnaire QL0742(A5001). 2006
103.
Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al: Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008, 86: 559-567. 10.2471/BLT.07.044248.PubMedPubMedCentral
Metadata
Title
Improving HIV outcomes in resource-limited countries: the importance of quality indicators
Authors
Aima A Ahonkhai
Ingrid V Bassett
Timothy G Ferris
Kenneth A Freedberg
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2012
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-12-427

Other articles of this Issue 1/2012

BMC Health Services Research 1/2012 Go to the issue

Research article

Multistate models for comparing trends in hospitalizations among young adult survivors of colorectal cancer and matched controls

Research article

What is preventable harm in healthcare? A systematic review of definitions

Research article

Health status and socio-economic factors associated with health facility utilization in rural and urban areas in Zambia

Research article

Migrating from user fees to social health insurance: exploring the prospects and challenges for hospital management

Research article

Factors influencing the development of evidence-based practice among nurses: a self-report survey

Research article

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults